Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum (Q31877287)

4 July 2017

Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum (English)

1 reference

4 July 2017

0 references

1 reference

1 reference

Westerink BH

1

1 reference

4 July 2017

Kawahara Y

2

1 reference

4 July 2017

De Boer P

3

1 reference

4 July 2017

Geels C

4

1 reference

4 July 2017

De Vries JB

5

1 reference

4 July 2017

Wikström HV

6

1 reference

4 July 2017

Van Kalkeren A

7

1 reference

4 July 2017

Van Vliet B

8

1 reference

4 July 2017

Kruse CG

9

1 reference

4 July 2017

Long SK

10

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

European Journal of Pharmacology

4 July 2017

1 reference

4 July 2017

412

1 reference

4 July 2017

127-138

1 reference

4 July 2017

2

1 reference

Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

The effect of acetylcholinesterase inhibition on the release of acetylcholine from the striatum in vivo: interaction with autoreceptor responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Overcoming the neuroleptic-induced deficit syndrome: clinical observations with remoxipride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Clozapine potently stimulates mesocortical dopamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900935-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(00)00935-3

1 reference

4 July 2017

1 reference